TestBankForClayton’sBasicPharmacologyforNurses19thEditionBy M
j m
ichelleJ.Willihnganz, Samuel L.Gurevitz,BruceClaytonComplete
m m
,Chapter m01:mDrug mDefinitions,mStandards,mandmInformationmSources mWillihnganz:
Cmlayton’sBasicPharmacology mforNurses, 19thEdition j
MULTIPLECHOICE
1. Whichname identifiesadruglisted bytheUSFood and mDru
j j j
mg Administration(FDA)?
j
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:mC
Theofficialnameisthemnameunderwhichadrug islistedbythem FD j
A.mThebrandname, ortrademark,mis thenamegiventoadrugmbyits
j j
manufacturer.mThe nonproprietary,morgeneric, mnameispr movided
j
bythemUnited States Adopted mNamesmCouncil.
j j
DIF: Cognitive Level:Knowledge j REF:mp.m9
OBJ:1NAT:NCLEXClientNeeds Category:Safe,mEffectiveCare mEnmvironmen
j
t TOP:mNursingmProcessmStep:mAssessment
j
CON:
PatientmEducation
2. Which sourcecontainsinformationspecifictonutritionalsupplements?
j
a. USPDictionaryofUSAN&Internationalm DrugNames
b. NaturalMedicinesComprehensiveDatabase
c. UnitedStatesPharmacopoeia/NationalFormulary(USPNF)
d. DrugInteractionFacts
ANS:mC
UnitedStatesPharmacopoeia/NationalFormularycontainsinformationspecificto nutritionalsum p j
plements.mUSPDictionaryofmUSAN&InternationalmDrugmNamesmisacompilation ofdrugnames,m j
pronunciationguide,mandpossiblefuturemFDAapproved drugs;mitdoesnotincludenutritionalsupplm
j
ements.mNaturalmMedicinesComprehensivemDatabasemcontains
evidence-
basedinformationonherbalmedicinesandherbalcombinationproducts;itdoesnotincludeinform mati
on specific tonutritionalsupplements.mDrugmInteractionFactsmcontainscomprehensiveinformamti
j j
onondruginteraction facts;mit does notincludenutritional supplements.
j j j j
DIF:m m Cognitive Level:mKnowledge
j REF:mp.m4
OBJ:3 mNAT:mNCLEXClientmNeedsmCategory:mPhysiologicalmIntegrit
y
TOP:m Nursing ProcessStep:Assessment CON:mNutrition |PatientmEducation
j j
3. Which drugreferencecontainsdrugmonographsthatdescribealldrugsin atherapeutic class?
j j j
a. DrugFactsandComparisons
,TestBank mFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 3
b. DrugInteractionFacts
c. Handbook onInjectablemDrugs j
d. Martindale—TheCompleteDrugReference
ANS:mA
DrugFactsandmComparisonsmcontainsdrug monographsthatdescribealldrugsin a therap j j j
meutic class.Monographsareformatted astablesto allowcomparison ofsimilar mproducts,mb
j j j j
rmandnames,mmanufacturers,m costindices, andavailabledosageformsmOnlineversionis av j j
aimlable.
DIF: CognitiveLevel:Knowledge REF:m p.m4 Table1.2 j
OBJ:m 3 NAT:mNCLEXClientNeeds Category:Physiological Integrity j j
TOP:m Nursing ProcessStep:Assessment CON:mSafety|PatientmEducation |ClinicalJudgment
j j
4. Whichdrug reference contains monographsabout virtuallyeverysingle-
j j j j
entitydrug available inthemUnited mStates anddescribestherapeuticusesofdrugs,mincludingappromvedanduna
j j j
pproveduses?
a. Martindale:TheCompleteDrugReference
b. AHFSDrugInformation
c. DrugReference
d. DrugFacts and Comparisons j j
ANS:mB
AHFSDrugmInformationcontainsmonographsabout virtuallyeverysingle- j
entitydrugavailableinthe UnitedStatesanddescribes therapeuticusesofdrugs,mincludingapprovemdandunap
j j
proveduses.
DIF: Cognitive Level:Knowledge REF:m p.m4 Table1.2
j j
OBJ:m 3 NAT:mNCLEXClientNeedsCategory:PhysiologicalIntegrity
TOP:m Nursing ProcessStep:Planning
j CON:mSafety|PatientmEducation |ClinicalJudgment j
5. Whichonlinedrug referencemakesavailabletohealthcareproviders andthepublicastandard,m m c
j j
omprehensive,mup-to-datelookup anddownloadableresourceabout medicines? j j
a. AmericanDrugIndex
b. AmericanHospitalFormulary
c. DailyMed
d. DrugReference
ANS:mC
DailyMedmakes availabletohealthcareprovidersandthepublica standard, comprehensive,mup-
j j j
mto-
datelookupanddownloadableresourceabout medicines.The AmericanDrugIndexisnotappropmria j j
te forpatientuse.mThemAmericanmHospitalmFormularymisnotappropriateforpatientuse.mThemdrumg
j
referencemisnotappropriateforpatientuse.
DIF:m m CognitivemLevel:mKnowledge REF:m p.m3 m|p.m4
OBJ:3 mNAT:mNCLEXClientmNeedsmCategory:mPhysiologicalmIntegrit
y
TOP:mNursingProcessStep:Implementation
CON:mSafety|Patient Education|ClinicalJudgment j
6. Which legislationauthorizestheFDAtodeterminethe safetyofa drugbeforeits marketing?
j j j j
a. FederalFood,Drug,and CosmeticAct(1938) j
b. Durham HumphreyAmendment(1952)
j
, TestBank mFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 4
c. ControlledSubstancesAct (1970) j
d. KefauverHarrisDrug Amendment(1962) j
ANS:mA
TheFederalmFood,mDrug,mand mCosmetic Actof m1938mauthorizedthemFDAtodetermine thesafetyof j j
amlldrugs before marketing.mLateramendmentsandacts helped tightenmFDAcontrolandensuredru
j j j j
g m safety.mThemDurhammHumphreyAmendmentdefinesthe kindsofdrugs thatcannotbeusedsafely
j j j
w mithoutmedicalsupervisionandrestrictstheirsaleto prescriptionbyalicensedpractitioner.The Com j j
m ntrolled SubstancesActaddresses onlycontrolled substancesand theircategorization. mThemKefa
j j j j
uvmerHarris DrugAmendment mensuresdrugefficacyand greaterdrugsafety.mDrug manufacturersa
j j j
rermequiredto proveto themFDAtheeffectivenessoftheirproducts beforemarketingthem.
j j j
DIF: CognitiveLevel:Knowledge
REF:mp.m5Tablel.3 mOBJ:m5
NAT:NCLEX Client NeedsCategory:PhysiologicalIntegrity mT j j
mOP:mNursingmProcess mStep:mAssessment
CON:mSafety|PatientmEducation|Evidence|HealthCare Law j
7. Whichclassificationdoesmeperidine(Demerol) fallunder? j
a. I
b. II
c. III
d. IV
ANS:mB
Meperidine (Demerol)m isamSchedulemII drug;mit has ahighpotentialforabuseandmaylead tosevere
j j j j j
mpsychologicalandphysicaldependence.ScheduleI d rugshavehighpotential forabuseand norecomgn j j j
ized medicaluse.mSchedulemIII drugs havesomempotentialforabuse.mUsemayleadto lowtomodemra
j j j j
tephysicaldependenceorhighpsychologicaldependence. mSchedulemIVmdrugshavelowpotentialmf
orabuse.mUse mayleadtolimitedphysicalorpsychologicaldependence.
j
DIF:m m CognitivemLevel:mKnowledge REF:mp.m10
OBJ:2 NAT:mNCLEX Client NeedsCategory:mSafe,mEffectiveCare Em
j j j j
nvironment
TOP:m Nursing ProcessStep:Assessmentm m m CON:mPatientmEducation|Addiction|Pain
j
8. WhichactionwouldtheFDAtaketoexpeditedrug development mandapprovalforan outbreak of msmm j j j
allpox?
a. Listsmallpoxas a health orphan disease. j j j j
b. Omitthepreclinicalresearchphase.
c. Extend the clinicalresearchphase.
j j
d. Fasttrack the investigationaldrug. j j
ANS:mD
Once themInvestigationalmNew mDrug Applicationhasbeenapproved,mthe drugcan receivehighestp
j j j j
mrioritywithintheagency, mwhichiscalledfasttracking. mAsmallpoxoutbreakwouldbecomeapriorim
tyconcernintheworld.mOrphandiseases arenotresearchedinaprioritymanner.mPreclinicalresearm c j
h ismnotomitted.mExtendinganyphase oftheresearchwould meanalongertimetodevelopavaccinme.
j j j
TheFDAmustensurethat allphasesofthepreclinicaland mclinical researchphasehavebeencom mplet
j j
ed ina safemanner.
j j
DIF: Cognitive Level:Knowledge j REF:m p.m7 OBJ:m5
j m
ichelleJ.Willihnganz, Samuel L.Gurevitz,BruceClaytonComplete
m m
,Chapter m01:mDrug mDefinitions,mStandards,mandmInformationmSources mWillihnganz:
Cmlayton’sBasicPharmacology mforNurses, 19thEdition j
MULTIPLECHOICE
1. Whichname identifiesadruglisted bytheUSFood and mDru
j j j
mg Administration(FDA)?
j
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:mC
Theofficialnameisthemnameunderwhichadrug islistedbythem FD j
A.mThebrandname, ortrademark,mis thenamegiventoadrugmbyits
j j
manufacturer.mThe nonproprietary,morgeneric, mnameispr movided
j
bythemUnited States Adopted mNamesmCouncil.
j j
DIF: Cognitive Level:Knowledge j REF:mp.m9
OBJ:1NAT:NCLEXClientNeeds Category:Safe,mEffectiveCare mEnmvironmen
j
t TOP:mNursingmProcessmStep:mAssessment
j
CON:
PatientmEducation
2. Which sourcecontainsinformationspecifictonutritionalsupplements?
j
a. USPDictionaryofUSAN&Internationalm DrugNames
b. NaturalMedicinesComprehensiveDatabase
c. UnitedStatesPharmacopoeia/NationalFormulary(USPNF)
d. DrugInteractionFacts
ANS:mC
UnitedStatesPharmacopoeia/NationalFormularycontainsinformationspecificto nutritionalsum p j
plements.mUSPDictionaryofmUSAN&InternationalmDrugmNamesmisacompilation ofdrugnames,m j
pronunciationguide,mandpossiblefuturemFDAapproved drugs;mitdoesnotincludenutritionalsupplm
j
ements.mNaturalmMedicinesComprehensivemDatabasemcontains
evidence-
basedinformationonherbalmedicinesandherbalcombinationproducts;itdoesnotincludeinform mati
on specific tonutritionalsupplements.mDrugmInteractionFactsmcontainscomprehensiveinformamti
j j
onondruginteraction facts;mit does notincludenutritional supplements.
j j j j
DIF:m m Cognitive Level:mKnowledge
j REF:mp.m4
OBJ:3 mNAT:mNCLEXClientmNeedsmCategory:mPhysiologicalmIntegrit
y
TOP:m Nursing ProcessStep:Assessment CON:mNutrition |PatientmEducation
j j
3. Which drugreferencecontainsdrugmonographsthatdescribealldrugsin atherapeutic class?
j j j
a. DrugFactsandComparisons
,TestBank mFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 3
b. DrugInteractionFacts
c. Handbook onInjectablemDrugs j
d. Martindale—TheCompleteDrugReference
ANS:mA
DrugFactsandmComparisonsmcontainsdrug monographsthatdescribealldrugsin a therap j j j
meutic class.Monographsareformatted astablesto allowcomparison ofsimilar mproducts,mb
j j j j
rmandnames,mmanufacturers,m costindices, andavailabledosageformsmOnlineversionis av j j
aimlable.
DIF: CognitiveLevel:Knowledge REF:m p.m4 Table1.2 j
OBJ:m 3 NAT:mNCLEXClientNeeds Category:Physiological Integrity j j
TOP:m Nursing ProcessStep:Assessment CON:mSafety|PatientmEducation |ClinicalJudgment
j j
4. Whichdrug reference contains monographsabout virtuallyeverysingle-
j j j j
entitydrug available inthemUnited mStates anddescribestherapeuticusesofdrugs,mincludingappromvedanduna
j j j
pproveduses?
a. Martindale:TheCompleteDrugReference
b. AHFSDrugInformation
c. DrugReference
d. DrugFacts and Comparisons j j
ANS:mB
AHFSDrugmInformationcontainsmonographsabout virtuallyeverysingle- j
entitydrugavailableinthe UnitedStatesanddescribes therapeuticusesofdrugs,mincludingapprovemdandunap
j j
proveduses.
DIF: Cognitive Level:Knowledge REF:m p.m4 Table1.2
j j
OBJ:m 3 NAT:mNCLEXClientNeedsCategory:PhysiologicalIntegrity
TOP:m Nursing ProcessStep:Planning
j CON:mSafety|PatientmEducation |ClinicalJudgment j
5. Whichonlinedrug referencemakesavailabletohealthcareproviders andthepublicastandard,m m c
j j
omprehensive,mup-to-datelookup anddownloadableresourceabout medicines? j j
a. AmericanDrugIndex
b. AmericanHospitalFormulary
c. DailyMed
d. DrugReference
ANS:mC
DailyMedmakes availabletohealthcareprovidersandthepublica standard, comprehensive,mup-
j j j
mto-
datelookupanddownloadableresourceabout medicines.The AmericanDrugIndexisnotappropmria j j
te forpatientuse.mThemAmericanmHospitalmFormularymisnotappropriateforpatientuse.mThemdrumg
j
referencemisnotappropriateforpatientuse.
DIF:m m CognitivemLevel:mKnowledge REF:m p.m3 m|p.m4
OBJ:3 mNAT:mNCLEXClientmNeedsmCategory:mPhysiologicalmIntegrit
y
TOP:mNursingProcessStep:Implementation
CON:mSafety|Patient Education|ClinicalJudgment j
6. Which legislationauthorizestheFDAtodeterminethe safetyofa drugbeforeits marketing?
j j j j
a. FederalFood,Drug,and CosmeticAct(1938) j
b. Durham HumphreyAmendment(1952)
j
, TestBank mFor Clayton’s BasicPharmacologyfor Nurses19thEdition
j j j 4
c. ControlledSubstancesAct (1970) j
d. KefauverHarrisDrug Amendment(1962) j
ANS:mA
TheFederalmFood,mDrug,mand mCosmetic Actof m1938mauthorizedthemFDAtodetermine thesafetyof j j
amlldrugs before marketing.mLateramendmentsandacts helped tightenmFDAcontrolandensuredru
j j j j
g m safety.mThemDurhammHumphreyAmendmentdefinesthe kindsofdrugs thatcannotbeusedsafely
j j j
w mithoutmedicalsupervisionandrestrictstheirsaleto prescriptionbyalicensedpractitioner.The Com j j
m ntrolled SubstancesActaddresses onlycontrolled substancesand theircategorization. mThemKefa
j j j j
uvmerHarris DrugAmendment mensuresdrugefficacyand greaterdrugsafety.mDrug manufacturersa
j j j
rermequiredto proveto themFDAtheeffectivenessoftheirproducts beforemarketingthem.
j j j
DIF: CognitiveLevel:Knowledge
REF:mp.m5Tablel.3 mOBJ:m5
NAT:NCLEX Client NeedsCategory:PhysiologicalIntegrity mT j j
mOP:mNursingmProcess mStep:mAssessment
CON:mSafety|PatientmEducation|Evidence|HealthCare Law j
7. Whichclassificationdoesmeperidine(Demerol) fallunder? j
a. I
b. II
c. III
d. IV
ANS:mB
Meperidine (Demerol)m isamSchedulemII drug;mit has ahighpotentialforabuseandmaylead tosevere
j j j j j
mpsychologicalandphysicaldependence.ScheduleI d rugshavehighpotential forabuseand norecomgn j j j
ized medicaluse.mSchedulemIII drugs havesomempotentialforabuse.mUsemayleadto lowtomodemra
j j j j
tephysicaldependenceorhighpsychologicaldependence. mSchedulemIVmdrugshavelowpotentialmf
orabuse.mUse mayleadtolimitedphysicalorpsychologicaldependence.
j
DIF:m m CognitivemLevel:mKnowledge REF:mp.m10
OBJ:2 NAT:mNCLEX Client NeedsCategory:mSafe,mEffectiveCare Em
j j j j
nvironment
TOP:m Nursing ProcessStep:Assessmentm m m CON:mPatientmEducation|Addiction|Pain
j
8. WhichactionwouldtheFDAtaketoexpeditedrug development mandapprovalforan outbreak of msmm j j j
allpox?
a. Listsmallpoxas a health orphan disease. j j j j
b. Omitthepreclinicalresearchphase.
c. Extend the clinicalresearchphase.
j j
d. Fasttrack the investigationaldrug. j j
ANS:mD
Once themInvestigationalmNew mDrug Applicationhasbeenapproved,mthe drugcan receivehighestp
j j j j
mrioritywithintheagency, mwhichiscalledfasttracking. mAsmallpoxoutbreakwouldbecomeapriorim
tyconcernintheworld.mOrphandiseases arenotresearchedinaprioritymanner.mPreclinicalresearm c j
h ismnotomitted.mExtendinganyphase oftheresearchwould meanalongertimetodevelopavaccinme.
j j j
TheFDAmustensurethat allphasesofthepreclinicaland mclinical researchphasehavebeencom mplet
j j
ed ina safemanner.
j j
DIF: Cognitive Level:Knowledge j REF:m p.m7 OBJ:m5
